# Atara Biotherapeutics, Inc.: Form 8-K, filed Oct 7, 2025

- Company: [Atara Biotherapeutics, Inc.](/companies/atra.md) (CIK 1604464)
- Form: 8-K
- Filed: 2025-10-07
- Accepted by EDGAR: Oct 6, 2025, 17:32 ET
- Period: 2025-10-06
- Accession: 0001193125-25-232117
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1604464/000119312525232117/d802811d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1604464/000119312525232117/

## Items reported

- Item 2.05: Exit or disposal costs

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1604464/000119312525232117/d802811d8k.htm

Filed Oct 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001193125-25-232117. Last ingested by Listed: Oct 24, 2026, 15:14 ET. No prices; not investment advice.